Indoco Remedies Ltd. said the U.K.'s Medicines and Healthcare Products Regulatory Agency recorded seven violations at its manufacturing plant in Goa, India.

The agency identified three critical and four major violations at the facility after a three-day inspection that ended March 16, the company said.

The company plans to resolve the issue and respond to the U.K. regulator at the earliest.

Mumbai, India-based Indoco manufactures and markets formulations and active pharmaceutical ingredients in India, U.S., the European Union, South Africa, Australia and New Zealand.